Association of obesity indices with in-hospital and 1-year mortality following acute coronary syndrome

Zuhur Balayah 1 2, Alawi A Alsheikh-Ali 1, Wafa Rashed 3, Wael Almahmeed 4, Arif Al Mulla 5, Najib Alrawahi 6, Samia Mora 7 8, Sagar B Dugani 9, Mohammad Zubaid 10

Affiliations

01 February 2021

-

doi: 10.1038/s41366-020-00679-0

Abstract

Background/objectives: According to the "obesity paradox", adults with obesity have a survival advantage following acute coronary syndrome, compared with those without obesity. Previous studies focused on peripheral obesity and whether this advantage is conferred by central obesity is unknown. The objective of this study was to describe the association of peripheral and central obesity indices with risk of in-hospital and 1-year mortality following acute coronary syndrome (ACS).

Subjects/methods: Gulf COAST is a prospective ACS registry that enrolled 4044 patients age ≥18 years from January 2012 through January 2013, across 29 hospitals in four Middle Eastern countries. Associations of indices of peripheral obesity (body-mass index, [BMI]) and central obesity (waist circumference [WC] and waist-to-height ratio [WHtR]) with mortality following ACS were analyzed in logistic regression models (odds ratio, 95% CI) with and without adjustment for Global Registry of Acute Coronary Events risk score.

Results: Of 3882 patients analyzed (mean age: 60 years; 33.3% women [n = 1294]), the prevalence of obesity was 34.5% (BMI ≥ 30.0 kg/m2), 72.2% (WC ≥ 94.0 cm [men] or ≥80.0 cm [women]) and 90.0% (WHtR ≥ 0.5). In adjusted models, deciles of obesity indices showed higher risk of mortality at extreme versus intermediate deciles (U-shaped). When defined by conventional cut-offs, peripheral obesity (BMI ≥ 30.0 versus 18.5-29.9 kg/m2) showed inverse association with risk of in-hospital mortality (0.64; 95% CI, 0.42-0.99; P = 0.04; central obesity showed trend toward reduced mortality). In contrast, for risk of 1-year mortality, all indices showed inverse association. Obesity, defined by presence of all three indices, versus nonobesity showed inverse association with risk of 1-year mortality (0.52; 95% CI, 0.35-0.75; P = 0.001). Results were similar among men and women.

Conclusion: The degree of obesity paradox following ACS depends on the obesity index and follow-up time. Obesity indices may aid in risk stratification of mortality following ACS.

Similar articles

The obesity paradox in patients with acute coronary syndrome: results from the Gulf RACE-2 study.

Shehab A, Al-Dabbagh B, AlHabib K, Alsheikh-Ali A, Almahmeed W, Sulaiman K, Al-Motarreb A, Suwaidi JA, Hersi A, AlFaleh H, Asaad N, AlSaif S, Amin H, Alanbaei M, Nagelkerke N, Abdulle A.Angiology. 2014 Aug;65(7):585-9. doi: 10.1177/0003319713497087. Epub 2013 Aug 5.PMID: 23921507 Clinical Trial.

Waist-to-height ratio, waist circumference, body mass index, waist divided by height0.5 and the risk of cardiometabolic multimorbidity: A national longitudinal cohort study.

Lu Y, Liu S, Qiao Y, Li G, Wu Y, Ke C.Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2644-2651. doi: 10.1016/j.numecd.2021.05.026. Epub 2021 Jun 4.PMID: 34226121

Comparison of body mass index, waist circumference, conicity index, and waist-to-height ratio for predicting incidence of hypertension: the rural Chinese cohort study.

Chen X, Liu Y, Sun X, Yin Z, Li H, Deng K, Cheng C, Liu L, Luo X, Zhang R, Liu F, Zhou Q, Wang C, Li L, Zhang L, Wang B, Zhao Y, Zhou J, Han C, Zhang H, Yang X, Pang C, Yin L, Feng T, Zhao J, Zhang M, Hu D.J Hum Hypertens. 2018 Mar;32(3):228-235. doi: 10.1038/s41371-018-0033-6. Epub 2018 Feb 7.PMID: 29416119

Comparative analysis of anthropometric indices of obesity as correlates and potential predictors of risk for hypertension and prehypertension in a population in Nigeria.

Ononamadu CJ, Ezekwesili CN, Onyeukwu OF, Umeoguaju UF, Ezeigwe OC, Ihegboro GO.Cardiovasc J Afr. 2017 Mar/Apr 23;28(2):92-99. doi: 10.5830/CVJA-2016-061. Epub 2016 Jul 13.PMID: 27701484 Free PMC article.

Prevalence and impact of cardiovascular risk factors among patients presenting with acute coronary syndrome in the middle East.

El-Menyar A, Zubaid M, Shehab A, Bulbanat B, Albustani N, Alenezi F, Al-Motarreb A, Singh R, Asaad N, Al Suwaidi J.Clin Cardiol. 2011 Jan;34(1):51-8. doi: 10.1002/clc.20873.PMID: 21259279 Free PMC article.

Cited by

Social Determinants of Health and Mortality After Premature and Non-premature Acute Coronary Syndrome.

Dugani SB, Zubaid M, Rashed W, Girardo ME, Balayah Z, Mora S, Alsheikh-Ali AA.Mayo Clin Proc Innov Qual Outcomes. 2023 Apr 22;7(3):153-164. doi: 10.1016/j.mayocpiqo.2023.03.002. eCollection 2023 Jun.PMID: 37152409 Free PMC article.

The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry.

Li YG, Xie PX, Alsheikh-Ali AA, AlMahmeed W, Sulaiman K, Asaad N, Liu SW, Zubaid M, Lip GYH.Front Cardiovasc Med. 2022 Nov 30;9:1032633. doi: 10.3389/fcvm.2022.1032633. eCollection 2022.PMID: 36531711 Free PMC article.

The value of nurse-led anthropometric and oropharyngeal measurements combined with STOP-Bang questionnaire in screening for obstructive sleep apnea in patients with acute coronary syndrome: a prospective cohort study.

Li Z, Miao H, Zhang S, Fan J, Yan Y, Gong W, Zheng W, Wang X, Que B, Ai H, Zhang L, Nie S.BMC Pulm Med. 2022 Nov 3;22(1):396. doi: 10.1186/s12890-022-02200-x.PMID: 36329414 Free PMC article.

Influence of Overweight and Obesity on Morbidity and Mortality among Hospitalized Patients in Sri Lanka: A Single-Center Analysis.

Dilrukshi MDSA, Thotamuna V, Senarath Yapa DJ, De Silva L, Ranasinghe P, Katulanda P.J Obes. 2022 Aug 18;2022:9172365. doi: 10.1155/2022/9172365. eCollection 2022.PMID: 36033432 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25. - PubMed - PMC
  2.  
    1. Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab. 2015;6(Suppl 2):7–12.
  3.  
    1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
  4.  
    1. Dugani SB, Moran AE, Bonow RO, Gaziano TA Ischemic Heart Disease: Cost-Effective Acute Management and Secondary Prevention. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, eds. Cardiovascular, Respiratory, and Related Disorders. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017;Chapter 8.
  5.  
    1. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32. - PubMed
  6.  
    1. Dehlendorff C, Andersen KK, Olsen TS. Body mass index and death by stroke: no obesity paradox. JAMA Neurol. 2014;71:978–84. - PubMed
  7.  
    1. Lavie CJ, Arena R, Alpert MA, Milani RV, Ventura HO. Management of cardiovascular diseases in patients with obesity. Nat Rev Cardiol. 2018;15:45–56. - PubMed
  8.  
    1. Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart. 2015;101:1631–38. - PubMed
  9.  
    1. Lavie CJ, Schutter AD, Milani RV. Body composition and the obesity paradox in coronary heart disease: can heavier really be healthier? Heart. 2015;101:1610–1. - PubMed
  10.  
    1. Obesity. preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1-253
  11.  
    1. Degoulet P, Legrain M, Réach I, Aimé F, Devriés C, Rojas P, et al. Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron. 1982;31:103–10. - PubMed
  12.  
    1. Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996;78:642–6. - PubMed
  13.  
    1. Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578–84. - PubMed
  14.  
    1. Chang S-H, Beason TS, Hunleth JM, Colditz GA. A systematic review of body fat distribution and mortality in older people. Maturitas. 2012;72:175–91. - PubMed - PMC
  15.  
    1. Bowman K, Atkins JL, Delgado J, Kos K, Kuchel GA, Ble A, et al. Central adiposity and the overweight risk paradox in aging: follow-up of 130,473 UK Biobank participants. Am J Clin Nutr. 2017;106:130–5. - PubMed - PMC
  16.  
    1. Neeland IJ, Poirier P, Després J-P. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137:1391–406. - PubMed - PMC
  17.  
    1. Yusufali A, Bazargani N, Muhammed K, Gabroun A, AlMazrooei A, Agrawal A, et al. Opportunistic screening for CVD risk factors: the Dubai shopping for cardiovascular risk study (DISCOVERY). Glob Heart. 2015;10:265–72. - PubMed
  18.  
    1. Aljefree N, Ahmed F. Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review. Adv Public Health. 2015;2015:235101.
  19.  
    1. Barakat H, Barakat H, Baaj MK. CVD and obesity in transitional Syria: a perspective from the Middle East. Vasc Health Risk Manag. 2012;8:145–50. - PubMed - PMC
  20.  
    1. Hammoudeh AJ, Alhaddad IA, Khader Y, Tabbalat R, Al-Mousa E, Saleh A, et al. Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: results from the first Jordanian percutaneous coronary intervention study. J Saudi Heart Assoc. 2017;29:195–202. - PubMed
  21.  
    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81. - PubMed - PMC
  22.  
    1. Abi Khalil C, Sulaiman K, Singh R, Jayyousi A, Asaad N, AlHabib K, et al. BMI is inversely correlated to the risk of mortality in patients with type 2 diabetes hospitalized for acute heart failure: findings from the Gulf aCute heArt failuRE (Gulf-CARE) registry. Int J Cardiol. 2017;241:262–9. - PubMed
  23.  
    1. Mobeirek AF, Al-Habib K, Al-Faleh H, Hersi A, Kashour T, Ullah A, et al. Absence of obesity paradox in Saudi patients admitted with acute coronary syndromes: insights from SPACE registry. Ann Saudi Med. 2014;34:38–45. - PubMed - PMC
  24.  
    1. Hadi HAR, Zubaid M, Al Mahmeed W, El-Menyar AA, Alsheikh-Ali AA, Singh R, et al. The prevalence and outcome of excess body weight among Middle Eastern patients presenting with acute coronary syndrome. Angiology. 2010;61:456–64. - PubMed
  25.  
    1. Shehab A, Al-Dabbagh B, AlHabib K, Alsheikh-Ali A, Almahmeed W, Sulaiman K, et al. The obesity paradox in patients with acute coronary syndrome: results from the Gulf RACE-2 study. Angiology. 2014;65:585–9. - PubMed
  26.  
    1. Jarrah M, Hammoudeh AJ, Khader Y, Tabbalat R, Al-Mousa E, Okkeh O, et al. Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients. J Int Med Res. 2018;46:1595–605. - PubMed - PMC
  27.  
    1. Niedziela J, Hudzik B, Niedziela N, Gąsior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29:801–12. - PubMed - PMC
  28.  
    1. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666–78. - PubMed
  29.  
    1. Zubaid M, Thani KB, Rashed W, Alsheikh-Ali A, Alrawahi N, Ridha M, et al. Design and rationale of gulf locals with acute coronary syndrome events (Gulf Coast) registry. Open Cardiovasc Med J. 2014;8:88–93. - PubMed - PMC
  30.  
    1. Weintraub WS, Karlsberg RP, Tcheng JE, Boris JR, Buxton AE, Dove JT, et al. ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health Records: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Journal of the American College of Cardiology. 2011;58:202–22. - PubMed
  31.  
    1. Bundhun PK, Li N, Chen M-H. Does an obesity paradox really exist after cardiovascular intervention?: a systematic review and meta-analysis of randomized controlled trials and observational studies. Medicine (Baltimore). 2015;94:e1910. - PubMed - PMC
  32.  
    1. Mariscalco G, Wozniak MJ, Dawson AG, Serraino GF, Porter R, Nath M, et al. Body mass index and mortality among adults undergoing cardiac surgery: a nationwide study with a systematic review and meta-analysis. Circulation. 2017;135:850–63. - PubMed
  33.  
    1. Preston SH, Stokes A. Obesity paradox: conditioning on disease enhances biases in estimating the mortality risks of obesity. Epidemiology. 2014;25:454–61. - PubMed - PMC
  34.  
    1. International Diabetes Federation. IDF consensus on worldwide definition of metabolic syndrome. International Diabetes Federation. https://www.idf.org/our-activities/advocacy-awareness/resources-and-tool... : Published 2005. Accessed 4 Feb 2018.
  35.  
    1. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutrition Research Reviews. 2010;23:247–69. - PubMed
  36.  
    1. Yusufali A, Zubaid M, Al-Zakwani I, Alsheikh-Ali AA, Al-Mallah MH, Al Suwaidi J, et al. Validation of the GRACE Risk score for hospital mortality in patients with acute coronary syndrome in the Arab Middle East. Angiology. 2011;62:390–6. - PubMed
  37.  
    1. Tang EW, Wong C-K, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007;153:29–35. - PubMed
  38.  
    1. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363:157–63.
  39.  
    1. Neeland IJ, Das SR, Simon DN, Diercks DB, Alexander KP, Wang TY, et al. The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR. Eur Heart J Qual Care Clin Outcomes. 2017;3:183–91. - PubMed - PMC
  40.  
    1. Angerås O, Albertsson P, Karason K, Råmunddal T, Matejka G, James S, et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013;34:345–53. - PubMed
  41.  
    1. Lamelas P, Schwalm J-D, Quazi I, Mehta S, Devereaux PJ, Jolly S, et al. Effect of body mass index on clinical events after acute coronary syndromes. Am J Cardiol. 2017;120:1453–9. - PubMed
  42.  
    1. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Køber L. TRACE study group. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol. 2005;98:123–31. - PubMed
  43.  
    1. Zeller M, Steg PG, Ravisy J, Lorgis L, Laurent Y, Sicard P, et al. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation. 2008;118:482–90. - PubMed
  44.  
    1. Kadakia MB, Fox CS, Scirica BM, Murphy SA, Bonaca MP, Morrow DA. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart. 2011;97:1782–7. - PubMed - PMC
  45.  
    1. Coutinho T, Goel K, Corrêa de Sá D, Kragelund C, Kanaya AM, Zeller M, et al. Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol. 2011;57:1877–86. - PubMed
  46.  
    1. Mohammadi H, Ohm J, Discacciati A, Sundstrom J, Hambraeus K, Jernberg T, et al. Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction. Eur J Prev Cardiol 2020; e-pub ahead of print. https://doi.org/10.1177/2047487319898019 .
  47.  
    1. Stringhini S, Carmeli C, Jokela M, Avendaño M, Muennig P, Guida F, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women. Lancet. 2017;389:1229–37. - PubMed - PMC
  48.  
    1. Jenkins DA, Bowden J, Robinson HA, Sattar N, Loos RJF, Rutter MK, et al. Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking. Diabetes Care. 2018;41:1878–86. - PubMed
  49.  
    1. Loos RJF. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012;26:211–26. - PubMed
  50.  
    1. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118:1752–70. - PubMed
  51.  
    1. Elagizi A, Kachur S, Lavie CJ, Carbone S, Pandey A, Ortega FB, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142–50. - PubMed
  52.  
    1. Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72:1506–31. - PubMed

Page Navigation